AARDEX Group is the leading source of reliable methods to assess medication adherence by ambulatory patients.
AARDEX Group provides unmatched services to improve patient adherence and maintain persistence with long-term treatments.
AARDEX Group combines recognized authority in biomedical and biostatistical research, experience in study design and analysis, and bioengineering capabilities to create highest value for our customers.
Learn more about how to:
Our strength in numbers:
The electronic and information technology aspects of MEMS™ monitoring are FDA 21 CRF, Part 11 compatible and meet all HIPAA Standards.
AARDEX Group is ISO 9001 qualified.